Latest filing published 13 Dec 2017 for Ocera Therapeutics, Inc.. Read the official filing
No signal scores available.
Filings by Domain Associates span 2 companies, the busiest being Ocera Therapeutics, Inc. and Tobira Therapeutics, Inc. Between 1 November 2016 and 11 December 2017, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 13 December 2017, reports a transaction in Ocera Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations